| | |

HBP-412 – Autoimmune Diseases HBP-412 is a second generation therapy which Hy BioPharma contemplates for treating Multiple Sclerosis (MS).

Home Page | Management team | Scientific Advisory Board
Hypericin Oncology | Hypericin Autoimmune Diseases | Pipeline | HBP-412 Autoimmune Diseases
Articles | Links | Contact us